Annals of the Rheumatic Diseases: 80 (7)

Editorial

Tenascin-C, a novel target to inhibit new bone formation in axial spondyloarthritis, linked with inflammation, mechanical strain and tissue damage (14 May, 2021) Free
Margot Van Mechelen, Rik Lories

Thinking the unthinkable

Rheumatology in 2049: the age of all data
(9 February, 2021)
Johanna Mucke, Philipp Sewerin, Matthias Schneider

Review

Tissue physiology revolving around the clock: circadian rhythms as exemplified by the intervertebral disc (4 January, 2021)
Honor Morris, Cátia F Gonçalves, Michal Dudek, Judith Hoyland, Qing-Jun Meng

Recommendation

EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs) (22 January, 2021) Free
Félicie Costantino, Loreto Carmona, Maarten Boers, Marina Backhaus, Peter V Balint, George A Bruyn, Robin Christensen, Philip G Conaghan, Ricardo J O Ferreira, Juan Luis Garrido-Castro, Francis Guillemin, Hilde Berner Hammer, Désirée van der Heijde, Annamaria Iagnocco, Marion C Kortekaas, Robert BM Landewé, Peter Mandl, Esperanza Naredo, Wolfgang A Schmidt, Lene Terslev, Caroline B Terwee, Ralf Thiele, Maria-Antonietta D'Agostino

Rheumatoid arthritis

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial (27 January, 2021)
Bernard Combe, Alan Kivitz, Yoshiya Tanaka, Désirée van der Heijde, J Abraham Simon, Herbert S B Baraf, Uma Kumar, Franziska Matzkies, Beatrix Bartok, Lei Ye, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Mark C Genovese, Neelufar Mozaffarian, Robert B M Landewé, Sang-Cheol Bae, Edward C Keystone, Peter Nash
Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA study (10 February, 2021)
Hieronymus TW Smeele, Esther Röder, Hetty M Wintjes, Laura JC Kranenburg-van Koppen, Johanna MW Hazes, Radboud JEM Dolhain
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib (19 March, 2021)
Paqui G Traves, Bernard Murray, Federico Campigotto, René Galien, Amy Meng, Julie A Di Paolo
Genetic variants shape rheumatoid arthritis-specific transcriptomic features in CD4⁺ T cells through differential DNA methylation, explaining a substantial proportion of heritability
(12 January, 2021) Free
Eunji Ha, So-Young Bang, Jiwoo Lim, Jun Ho Yun, Jeong-Min Kim, Jae-Bum Bae, Hye-Soon Lee, Bong-Jo Kim, Kwangwoo Kim, Sang-Cheol Bae

Inflammatory arthritis

Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis (12 January, 2021)
Irina Gessl, Mihaela Popescu, Victoria Schimpl, Gabriela Supp, Thomas Deimel, Martina Durechova, Miriam Hucke, Michaela Loiskandl, Paul Studenic, Michael Zauner, Josef S Smolen, Daniel Aletaha, Peter Mandl

Spondyloarthritis

Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis (15 April, 2021)
Zihao Li, Siwen Chen, Haowen Cui, Xiang Li, Dongying Chen, Wenjun Hao, Jianru Wang, Zemin Li, Zhaomin Zheng, Zhongping Zhang, Hui Liu

Pain

Maintaining musculoskeletal health using a behavioural therapy approach: a population-based randomised controlled trial (the MAmMOTH Study) (1 February, 2021)
Gary J Macfarlane, Marcus Beasley, Neil Scott, Huey Chong, Paul McNamee, John McBeth, Neil Basu, Philip C Hannaford, Gareth T Jones, Phil Keeley, Gordon J Prescott, Karina Lovell

Systemic sclerosis

Autoantibodies targeting telomere-associated proteins in systemic sclerosis (25 January, 2021)
Brittany L Adler, Francesco Boin, Paul J Wolters, Clifton O Bingham, Ami A Shah, Carol Greider, Livia Casciola-Rosen, Antony Rosen
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma (4 February, 2021)
Rebecca L Ross, Clarissa Corinaldesi, Gemma Migneco, Ian M Carr, Agne Antanaviciute, Christopher W Wasson, Antonio Carriero, Jörg H W Distler, Steve Holmes, Yasser M El-Sherbiny, Clive S McKimmie, Francesco Del Galdo

Epidemiology

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (27 January, 2021)
Anja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, Saskia Lawson-Tovey, Jean W Liew, Lotta Ljung, Elsa F Mateus, Christophe Richez, Maria J Santos, Gabriela Schmajuk, Carlo A Scirè, Emily Sirotich, Jeffrey A Sparks, Paul Sufka, Thierry Thomas, Laura Trupin, Zachary S Wallace, Sarah Al-Adely, Javier Bachiller-Corral, Suleman Bhana, Patrice Cacoub, Loreto Carmona, Ruth Costello, Wendy Costello, Laure Gossec, Rebecca Grainger, Eric Hachulla, Rebecca Hasseli, Jonathan S Hausmann, Kimme L Hyrich, Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Lianne Kearsley-Fleet, Philip C Robinson, Jinoos Yazdany, Pedro M Machado
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts (21 January, 2021)
Angel YS Wong, Brian MacKenna, Caroline E Morton, Anna Schultze, Alex J Walker, Krishnan Bhaskaran, Jeremy P Brown, Christopher T Rentsch, Elizabeth Williamson, Henry Drysdale, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J Curtis, Amir Mehrkar, David Evans, Peter Inglesby, Jonathan Cockburn, Helen I McDonald, Laurie Tomlinson, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M Eggo, John Parry, Frank Hester, Sam Harper, Stephen JW Evans, Liam Smeeth, Ian J Douglas, Ben Goldacre

Letters

SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists (23 February, 2021)
Roberta Priori, Greta Pellegrino, Serena Colafrancesco, Cristiano Alessandri, Fulvia Ceccarelli, Manuela Di Franco, Valeria Riccieri, Rossana Scrivo, Antonio Sili Scavalli, Francesca Romana Spinelli, Fabrizio Conti
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE) (22 February, 2021)
Daniel J Wallace, Florence Figueras, William A Wegener, David M Goldenberg
Validation of the 2019 ACR/EULAR criteria for IgG4-related disease in a Japanese kidney disease cohort: a multicentre retrospective study by the IgG4-related kidney disease working group of the Japanese Society of Nephrology (23 February, 2021)
Takako Saeki, Tasuku Nagasawa, Yoshifumi Ubara, Yoshinori Taniguchi, Motoko Yanagita, Shinichi Nishi, Michio Nagata, Yutaka Yamaguchi, Takao Saito, Hitoshi Nakashima, Mitsuhiro Kawano
Bone loss in patients with SAPHO syndrome: a preliminary study (15 February, 2021)
Xiao Chen, Miaomiao Wang, Wenjing Cui, Zhongqiu Wang

Electronic pages

Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study (19 November, 2019) Free
Jun Inamo
Response to: ‘Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study’ by Inamo (28 November, 2019) Free
Deshire Alpizar Rodriguez, Till Robin Lesker, Benoît Gilbert, Till Strowig, Axel Finckh
Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease (21 August, 2019) Free
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao
Response to: ‘Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease’ by Lai et al
(31 August, 2019) Free
Laurence Fardet, Irene Petersen, Irwin Nazareth
MS score in systemic juvenile idiopathic arthritis: suitable for routine use? (2 August, 2019) Free
Huihui Chi, Zhihong Wang, Chengde Yang, Yutong Su
Response to: ‘MS score in systemic juvenile idiopathic arthritis: suitable for routine use?’ by Chi et al
(16 August, 2019) Free
Francesca Minoia, Angelo Ravelli
Correspondence to ‘Time to change the primary outcome of lupus trials’ (16 August, 2019) Free
Shereen Oon, Molla Huq, Mandana Nikpour
Response to Correspondence to ‘Time to change the primary outcome of lupus trials’ by Oon et al
(20 August, 2019) Free
Frederic A Houssiau
Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome? (16 August, 2019) Free
Guillaume Coiffier, Amélie Martel, Jean-David Albert, Alain Lescoat, Aurore Bleuzen, Aleth Perdriger, Michel De Bandt, François Maillot
Response to: ‘Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?’ by Coiffier et al
(10 October, 2019) Free
Sandrine Jousse-Joulin, Maria Antonietta D'Agostino, Alojzija Hočevar, Esperanza Naredo, Lene Terslev, Sarah Ohrndorf, Annamaria Iagnocco, Wolfgang A Schmidt, Stephanie Finzel, Zarrin Alavi, George A W Bruyn
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis (3 August, 2019) Free
Corrado Campochiaro, Giacomo De Luca, Maria De Santis
Response to: ‘Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis’ by Campochiaro et al
(20 September, 2019) Free
Lionel Spielmann, François Séverac, Alain Meyer
Correspondence on ‘Standardisation of myositis-specific antibodies: where are we today?’ (6 September, 2019) Free
Maria Infantino, Mariangela Manfredi, Nicola Bizzaro
Response to: ‘Comment on: standardisation of myositis-specific antibodies: where are we today?’ by Infantino et al
(15 October, 2019) Free
Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg
Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype (24 August, 2019) Free
Latika Gupta, Sakir Ahmed, Bharati Singh, Satya Prakash, Shubha Phadke, Amita Aggarwal
Response to: ‘Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype’ by Gupta et al
(6 September, 2019) Free
Charlotte Eijkelboom, Nienke M Ter Haar, Joost Frenkel, Marco Gattorno
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials (10 May, 2019) Free
Ioannis Parodis, Mandana Nikpour
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list? (12 June, 2019) Free
Emanuel Raschi, Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Fabrizio De Ponti
Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab (16 April, 2019)
Francesco Muratore, Carlo Salvarani

Main menu

Table of contents

July 2021 - Volume 80 - 7

Editorial

Thinking the unthinkable

Review

Recommendation

Rheumatoid arthritis

Inflammatory arthritis

Spondyloarthritis

Pain

Systemic sclerosis

Epidemiology

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

July 2021 - Volume 80 - 7

Editorial

Thinking the unthinkable

Review

Recommendation

Rheumatoid arthritis

Inflammatory arthritis

Spondyloarthritis

Pain

Systemic sclerosis

Epidemiology

Letters

Electronic pages

Issue Information